Cite
HARVARD Citation
Belay, S. et al. (2021). A Bayesian adaptive design for biosimilar trials with time‐to‐event endpoint. Pharmaceutical statistics. pp. 597-609. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Belay, S. et al. (2021). A Bayesian adaptive design for biosimilar trials with time‐to‐event endpoint. Pharmaceutical statistics. pp. 597-609. [Online].